鑫科材料(600255.SH):擬投資6.47億元建年產1.8萬噸精密電子銅帶項目
格隆匯1月6日丨鑫科材料(600255.SH)公佈,根據公司未來發展戰略和產業佈局,為滿足高端精密電子銅帶產品的市場需求,進一步增強公司在高精密度電子銅帶行業的競爭力,公司擬與鷹潭炬能人才科技有限公司(“炬能科技”)簽訂《出資協議》共同出資設立江西鑫科電子材料有限公司(暫定名,以工商行政管理部門核准登記為準,“江西鑫科”)並投資建設年產1.8萬噸精密電子銅帶項目,項目總投資為6.47億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.